Corneal nerve loss as a surrogate marker for poor pial collaterals in patients with acute ischemic stroke

Adnan Khan, Ajay Menon, Naveed Akhtar, Saadat Kamran, Ahmad Muhammad, Georgios Ponirakis, Hoda Gad, Ioannis N. Petropoulos, Faisal Wadiwala, Blessy Babu, Adeeb Narangoli, Pablo García Bermejo, Hanadi Al Hamad, Marwan Ramadan, Peter Woodruff, Mark Santos, Maher Saqqur, Ashfaq Shuaib, Rayaz A. MalikScientific 2021 · DOI

Introduction

In the management of acute ischemic stroke, the presence of robust pial collaterals—a secondary network of blood vessels—is a critical determinant of clinical outcomes. These vessels maintain blood flow to the ischemic penumbra, the salvageable brain tissue surrounding the core of the stroke. Patients with superior collateral circulation typically experience smaller infarct volumes and better functional recovery. However, assessing collateral status currently requires complex and invasive imaging techniques like Computed Tomography Angiography (CTA). There is a significant clinical need for non-invasive, systemic biomarkers that can reflect a patient's underlying neurovascular health and "collateral reserve."

Methods

This study investigated whether Corneal Confocal Microscopy (CCM), a rapid and non-invasive ophthalmic imaging tool, could serve as a surrogate marker for pial collateral status. The researchers compared 35 patients with acute ischemic stroke (specifically middle cerebral artery occlusion) against 35 healthy, age-matched controls.

Stroke patients were categorized into "poor" (n=12) or "moderate-good" (n=23) collateral groups based on dynamic CTA scoring. All participants underwent CCM to capture high-resolution images of the corneal sub-basal nerve plexus and endothelial cells. Automated software was used to quantify several parameters:

  • Corneal Nerve Fiber Length (CNFL)
  • Corneal Nerve Fiber Density (CNFD)
  • Corneal Nerve Branch Density (CNBD)
  • Endothelial Morphology (including cell density, area, and shape)

Results

The study found significant differences in corneal nerve morphology between stroke patients and healthy controls. Specifically, CNFL, CNFD, and CNBD were significantly lower in the stroke group (P < 0.025).

Crucially, when comparing stroke patients based on their collateral status, those with poor pial collaterals exhibited significantly greater nerve loss. CNFL was markedly lower in the poor collateral group (16.26 ± 5.84 mm/mm²) compared to the moderate-good collateral group (20.76 ± 5.22 mm/mm², P=0.026). Similarly, CNBD was significantly reduced in patients with poor collaterals (P=0.044). In contrast, clinical parameters such as age, BMI, and blood pressure, as well as corneal endothelial cell metrics, did not differ significantly between the collateral subgroups.

Table 2: Comparison of corneal nerve and endothelial cell parameters between controls and stroke patients stratified by collateral status.

The diagnostic utility of these nerve metrics was further evaluated using Receiver Operating Characteristic (ROC) analysis. CNFL and CNBD were able to distinguish between poor and good pial collaterals with an Area Under the Curve (AUC) of 72% and 71%, respectively.

Table 3: Diagnostic performance of corneal nerve parameters in identifying poor pial collateral status.

Discussion

The findings support the hypothesis that the eye can serve as a "window to the brain." The cornea is the most densely innervated tissue in the human body, and the trigeminal nerve fibers supplying it may mirror the state of the small vessels and nerves within the cerebral environment. The "rarefaction" or thinning of these corneal nerves appears to correlate with a similar lack of robust collateral vessels in the brain.

Interestingly, the study suggests that this nerve loss is likely a pre-existing condition rather than a direct result of the acute stroke event. Chronic conditions like hypertension or diabetes may lead to systemic neurovascular damage, manifesting as both reduced corneal nerve density and a diminished collateral network. Consequently, patients with poor corneal nerve health may be more vulnerable to severe outcomes when a stroke occurs due to their lack of "backup" circulation.

Conclusion

Corneal nerve loss is significantly greater in stroke patients with poor pial collaterals. CCM offers a promising, non-invasive method to identify patients with a high risk of poor recovery due to inadequate collateral support. While this pilot study is limited by its sample size and the requirement for patients to remain still during imaging, it paves the way for larger longitudinal studies. Future research will determine if corneal nerve health can predict response to treatments like mechanical thrombectomy, potentially integrating rapid eye scans into emergency stroke protocols.

Summary updated

Abstract

In patients with acute ischemic stroke, pial collaterals play a key role in limiting neurological disability by maintaining blood flow to ischemic penumbra. We hypothesized that patient with poor pial collaterals will have greater corneal nerve and endothelial cell abnormalities. In a cross-sectional study, 35 patients with acute ischemic stroke secondary to middle cerebral artery (MCA) occlusion with poor (n = 12) and moderate-good (n = 23) pial collaterals and 35 healthy controls underwent corneal confocal microscopy and quantification of corneal nerve and endothelial cell morphology. In patients with MCA stroke, corneal nerve fibre length (CNFL) (P < 0.001), corneal nerve fibre density (CNFD) (P = 0.025) and corneal nerve branch density (CNBD) (P = 0.002) were lower compared to controls. Age, BMI, cholesterol, triglycerides, HDL, LDL, systolic blood pressure, NIHSS and endothelial cell parameters did not differ but mRS was higher (p = 0.023) and CNFL (p = 0.026) and CNBD (p = 0.044) were lower in patients with poor compared to moderate-good collaterals. CNFL and CNBD distinguished subjects with poor from moderate-good pial collaterals with an AUC of 72% (95% CI 53-92%) and 71% (95% CI 53-90%), respectively. Corneal nerve loss is greater in patients with poor compared to moderate-good pial collaterals and may act as a surrogate marker for pial collateral status in patients with ischemic stroke.
BibTeX
@inproceedings{khan2021corneal,
  author = {Adnan Khan and Ajay Menon and Naveed Akhtar and Saadat Kamran and Ahmad Muhammad and Georgios Ponirakis and Hoda Gad and Ioannis N. Petropoulos and Faisal Wadiwala and Blessy Babu and Adeeb Narangoli and Pablo García Bermejo and Hanadi Al Hamad and Marwan Ramadan and Peter Woodruff and Mark Santos and Maher Saqqur and Ashfaq Shuaib and Rayaz A. Malik},
  title = {{Corneal nerve loss as a surrogate marker for poor pial collaterals in patients with acute ischemic stroke}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-021-99131-0},
}
Figure